These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 11007434)
1. Heterogeneous chromosomal aberrations in intraductal breast lesions adjacent to invasive carcinoma. Aubele M; Cummings M; Walsch A; Zitzelsberger H; Nährig J; Höfler H; Werner M Anal Cell Pathol; 2000; 20(1):17-24. PubMed ID: 11007434 [TBL] [Abstract][Full Text] [Related]
2. Extensive ductal carcinoma In situ with small foci of invasive ductal carcinoma: evidence of genetic resemblance by CGH. Aubele M; Mattis A; Zitzelsberger H; Walch A; Kremer M; Welzl G; Höfler H; Werner M Int J Cancer; 2000 Jan; 85(1):82-6. PubMed ID: 10585588 [TBL] [Abstract][Full Text] [Related]
3. Evidence of chromosomal alterations in pure usual ductal hyperplasia as a breast carcinoma precursor. Xu S; Wei B; Zhang H; Qing M; Bu H Oncol Rep; 2008 Jun; 19(6):1469-75. PubMed ID: 18497952 [TBL] [Abstract][Full Text] [Related]
4. Accumulation of chromosomal imbalances from intraductal proliferative lesions to adjacent in situ and invasive ductal breast cancer. Aubele MM; Cummings MC; Mattis AE; Zitzelsberger HF; Walch AK; Kremer M; Höfler H; Werner M Diagn Mol Pathol; 2000 Mar; 9(1):14-9. PubMed ID: 10718208 [TBL] [Abstract][Full Text] [Related]
5. 20q13.2 amplification in intraductal hyperplasia adjacent to in situ and invasive ductal carcinoma of the breast. Werner M; Mattis A; Aubele M; Cummings M; Zitzelsberger H; Hutzler P; Höfler H Virchows Arch; 1999 Nov; 435(5):469-72. PubMed ID: 10592049 [TBL] [Abstract][Full Text] [Related]
6. Intratumoral heterogeneity in breast carcinoma revealed by laser-microdissection and comparative genomic hybridization. Aubele M; Mattis A; Zitzelsberger H; Walch A; Kremer M; Hutzler P; Höfler H; Werner M Cancer Genet Cytogenet; 1999 Apr; 110(2):94-102. PubMed ID: 10214356 [TBL] [Abstract][Full Text] [Related]
7. Identification of copy number alterations associated with the progression of DCIS to invasive ductal carcinoma. Johnson CE; Gorringe KL; Thompson ER; Opeskin K; Boyle SE; Wang Y; Hill P; Mann GB; Campbell IG Breast Cancer Res Treat; 2012 Jun; 133(3):889-98. PubMed ID: 22052326 [TBL] [Abstract][Full Text] [Related]
8. Genetic changes at specific stages of breast cancer progression detected by comparative genomic hybridization. Gao Y; Niu Y; Wang X; Wei L; Lu S J Mol Med (Berl); 2009 Feb; 87(2):145-52. PubMed ID: 18936904 [TBL] [Abstract][Full Text] [Related]
9. Evidence that molecular changes in cells occur before morphological alterations during the progression of breast ductal carcinoma. Castro NP; Osório CA; Torres C; Bastos EP; Mourão-Neto M; Soares FA; Brentani HP; Carraro DM Breast Cancer Res; 2008; 10(5):R87. PubMed ID: 18928525 [TBL] [Abstract][Full Text] [Related]
10. Ductal epithelial proliferations of the breast: a biological continuum? Comparative genomic hybridization and high-molecular-weight cytokeratin expression patterns. Boecker W; Buerger H; Schmitz K; Ellis IA; van Diest PJ; Sinn HP; Geradts J; Diallo R; Poremba C; Herbst H J Pathol; 2001 Nov; 195(4):415-21. PubMed ID: 11745672 [TBL] [Abstract][Full Text] [Related]
11. Genetic changes in intraductal breast cancer detected by comparative genomic hybridization. Kuukasjärvi T; Tanner M; Pennanen S; Karhu R; Kallioniemi OP; Isola J Am J Pathol; 1997 Apr; 150(4):1465-71. PubMed ID: 9095001 [TBL] [Abstract][Full Text] [Related]
12. Comparative genomic hybridization of ductal carcinoma in situ of the breast-evidence of multiple genetic pathways. Buerger H; Otterbach F; Simon R; Poremba C; Diallo R; Decker T; Riethdorf L; Brinkschmidt C; Dockhorn-Dworniczak B; Boecker W J Pathol; 1999 Mar; 187(4):396-402. PubMed ID: 10398097 [TBL] [Abstract][Full Text] [Related]
13. Quantitative analysis of allele imbalance supports atypical ductal hyperplasia lesions as direct breast cancer precursors. Larson PS; de las Morenas A; Cerda SR; Bennett SR; Cupples LA; Rosenberg CL J Pathol; 2006 Jul; 209(3):307-16. PubMed ID: 16604511 [TBL] [Abstract][Full Text] [Related]
14. Detection of gene amplification in intraductal and infiltrating breast cancer by laser-assisted microdissection and quantitative real-time PCR. Glöckner S; Lehmann U; Wilke N; Kleeberger W; Länger F; Kreipe H Pathobiology; 2000; 68(4-5):173-9. PubMed ID: 11279343 [TBL] [Abstract][Full Text] [Related]
15. Comparison of HER2 amplification status among breast cancer subgroups offers new insights in pathways of breast cancer progression. Lambein K; Van Bockstal M; Vandemaele L; Van den Broecke R; Cocquyt V; Geenen S; Denys H; Libbrecht L Virchows Arch; 2017 Nov; 471(5):575-587. PubMed ID: 28567637 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of numerical abnormalities of chromosomes 1 and 17 in proliferative epithelial breast lesions using fluorescence in situ hybridization. Marinho AF; Botelho M; Schmitt FC Pathol Res Pract; 2000; 196(4):227-33. PubMed ID: 10782466 [TBL] [Abstract][Full Text] [Related]
17. Loss of heterozygosity analyses of asynchronous lesions of ductal carcinoma in situ and invasive ductal carcinoma of the human breast. Amari M; Moriya T; Ishida T; Harada Y; Ohnuki K; Takeda M; Sasano H; Horii A; Ohuchi N Jpn J Clin Oncol; 2003 Nov; 33(11):556-62. PubMed ID: 14711979 [TBL] [Abstract][Full Text] [Related]
18. Widespread chromosomal abnormalities in high-grade ductal carcinoma in situ of the breast. Comparative genomic hybridization study of pure high-grade DCIS. Moore E; Magee H; Coyne J; Gorey T; Dervan PA J Pathol; 1999 Mar; 187(4):403-9. PubMed ID: 10398098 [TBL] [Abstract][Full Text] [Related]
19. Genomic differences between pure ductal carcinoma in situ of the breast and that associated with invasive disease: a calibrated aCGH study. Iakovlev VV; Arneson NC; Wong V; Wang C; Leung S; Iakovleva G; Warren K; Pintilie M; Done SJ Clin Cancer Res; 2008 Jul; 14(14):4446-54. PubMed ID: 18628458 [TBL] [Abstract][Full Text] [Related]
20. Progression-specific genes identified in microdissected formalin-fixed and paraffin-embedded tissue containing matched ductal carcinoma in situ and invasive ductal breast cancers. Schultz S; Bartsch H; Sotlar K; Petat-Dutter K; Bonin M; Kahlert S; Harbeck N; Vogel U; Seeger H; Fehm T; Neubauer HJ BMC Med Genomics; 2018 Sep; 11(1):80. PubMed ID: 30236106 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]